» Articles » PMID: 32747956

A Polycyclic Aromatic Hydrocarbon-enriched Environmental Chemical Mixture Enhances AhR, Antiapoptotic Signaling and a Proliferative Phenotype in Breast Cancer Cells

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2020 Aug 5
PMID 32747956
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Emerging evidence suggests the role of environmental chemicals, in particular endocrine-disrupting chemicals (EDCs), in progression of breast cancer and treatment resistance, which can impact survival outcomes. However, most research tends to focus on tumor etiology and the effect of single chemicals, offering little insight into the effects of realistic complex mixture exposures on tumor progression. Herein, we investigated the effect of a polycyclic aromatic hydrocarbon (PAH)-enriched EDC mixture in a panel of normal and breast cancer cells and in a tumor organoid model. Cells or organoids in culture were treated with EDC mixture at doses estimated from US adult intake of the top four PAH compounds within the mixture from the National Health and Nutrition Examination Survey database. We demonstrate that low-dose PAH mixture (6, 30 and 300 nM) increased aryl hydrocarbon receptor (AhR) expression and CYP activity in estrogen receptor (ER) positive but not normal mammary or ER-negative breast cancer cells, and that upregulated AhR signaling corresponded with increased cell proliferation and expression of antiapoptotic and antioxidant proteins XIAP and SOD1. We employed a mathematical model to validate PAH-mediated increases in AhR and XIAP expression in the MCF-7 ER-positive cell line. Furthermore, the PAH mixture caused significant growth increases in ER-negative breast cancer cell derived 3D tumor organoids, providing further evidence for the role of a natural-derived PAH mixture in enhancing a tumor proliferative phenotype. Together, our integrated cell signaling, computational and phenotype analysis reveals the underlying mechanisms of EDC mixtures in breast cancer progression and survival.

Citing Articles

Double-Edged Sword Effect of Diet and Nutrition on Carcinogenic Molecular Pathways in Breast Cancer.

Neagu A, Josan C, Jayaweera T, Weraduwage K, Nuru N, Darie C Int J Mol Sci. 2024; 25(20).

PMID: 39456858 PMC: 11508170. DOI: 10.3390/ijms252011078.


The dynamic relationship between skin microbiomes and personal care products: A comprehensive review.

Mim M, Sikder M, Chowdhury M, Bhuiyan A, Zinan N, Islam S Heliyon. 2024; 10(14):e34549.

PMID: 39104505 PMC: 11298934. DOI: 10.1016/j.heliyon.2024.e34549.


Deciphering the Chemotherapeutic Role of the Aryl Hydrocarbon Receptor Antagonist Resveratrol against the High-Penetrance Genes of Triple-Negative Breast Cancer.

Chatterjee P, Karn R, Emerson I A, Banerjee S ACS Omega. 2024; 9(28):30350-30363.

PMID: 39035954 PMC: 11256332. DOI: 10.1021/acsomega.4c01317.


Mapping the influence of hydrocarbons mixture on molecular mechanisms, involved in breast and lung neoplasms: in silico toxicogenomic data-mining.

Abu-Bakar A, Ismail M, Zulkifli M, Zaini N, Shukor N, Harun S Genes Environ. 2024; 46(1):15.

PMID: 38982523 PMC: 11232146. DOI: 10.1186/s41021-024-00310-y.


The Aryl Hydrocarbon Receptor: Impact on the Tumor Immune Microenvironment and Modulation as a Potential Therapy.

Griffith B, Frankel T Cancers (Basel). 2024; 16(3).

PMID: 38339226 PMC: 10854841. DOI: 10.3390/cancers16030472.


References
1.
Fillmann G, Watson G, Howsam M, Francioni E, Depledge M, Readman J . Urinary PAH metabolites as biomarkers of exposure in aquatic environments. Environ Sci Technol. 2004; 38(9):2649-56. DOI: 10.1021/es0350839. View

2.
Abdelrahim M, Ariazi E, Kim K, Khan S, Barhoumi R, Burghardt R . 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha. Cancer Res. 2006; 66(4):2459-67. DOI: 10.1158/0008-5472.CAN-05-3132. View

3.
Heger S, Bluhm K, Brendt J, Mayer P, Anders N, Schaffer A . Microscale In Vitro Assays for the Investigation of Neutral Red Retention and Ethoxyresorufin-O-Deethylase of Biofuels and Fossil Fuels. PLoS One. 2016; 11(9):e0163862. PMC: 5042516. DOI: 10.1371/journal.pone.0163862. View

4.
Soerjomataram I, Louwman M, Ribot J, Roukema J, Coebergh J . An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat. 2007; 107(3):309-30. PMC: 2217620. DOI: 10.1007/s10549-007-9556-1. View

5.
Birnbaum L, Fenton S . Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect. 2003; 111(4):389-94. PMC: 1241417. DOI: 10.1289/ehp.5686. View